NCT00395408View on ClinicalTrials.gov

Linear Growth Study (0476-097)(COMPLETED)

PHASE4CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Asthma
Interventions
DRUG

MK0476, montelukast sodium / Duration of Treatment : 56 Weeks

DRUG

Comparator : beclomethasone dipropionate / Duration of Treatment : 56 Weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00395408 - Linear Growth Study (0476-097)(COMPLETED) | Biotech Hunter | Biotech Hunter